Reactivation of hepatitis B refers to the abrupt increase in hepatitis B virus (HBV) replication
in a patient with inactive or resolved hepatitis B. Reactivation can occur spontaneously, but …

Patients with chronic HBV infection are at risk of reactivation of HBV should they require
immunosuppressive therapies for a variety of clinical settings, including chemotherapy for …

Abstract Background & Aim Hepatitis B reactivation related to the use of immunosuppressive
therapy remains a major cause of liver-related morbidity and mortality in hepatitis B endemic …

Background & Aims: Hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) is a
unique episomal replicative intermediate responsible for persistent infection of hepatocytes …

Acute flares in chronic hepatitis B are common and may be caused by a number of
identifiable and potentially treatable factors. The common link for many of these …

Chronic hepatitis B virus (HBV) infection remains a major health problem affecting
approximately 400 million people worldwide. Although HBV replication is only mildly …

Reactivation of hepatitis B virus (HBV) has been reported not only in HBsAg-positive
patients undergoing systemic chemotherapy, but also in a proportion of HBsAg-negative …

The Drafting Committee for Hepatitis Management Guidelines established by the Japan
Society of Hepatology published the first version of the Guidelines for the Management of …

Hepatitis B virus (HBV) reactivation is a serious but preventable complication of
immunosuppression. Full HBV serologic profile must be obtained from all patients receiving …

Reactivation of resolved hepatitis B virus (HBV) infection has been reported in allogeneic
hematopoetic stem cell transplantation (HSCT) recipients, but its epidemiology is not well …